Hematologic Oncology Update
Hematologic Oncology Update
✓

Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

· näytä muistiinpanot
01:02:25
Podcasts
RSS
Link

TIETOJA TÄSTÄ JAKSOSTA

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:

  • Multiple Myeloma (0:00)
  • Introduction: ESMO 2026; Recent FDA Approvals (1:53)
  • Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)
  • Bispecific Antibodies — Dr Lonial (19:16)
  • Antibody-Drug Conjugates — Dr Richardson (37:08)
  • Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10)

CME information and select publications

Tiede
Lääketiede
Englanti
Yhdysvallat
KäytäAPI:tä tämän jakson hakemiseenJSON:ssä

TÄSSÄ EPISODISSA

Muokkaa näitä tunnisteita

NÄYTÄ HUOMAUTUKSIA 🔗

00:00:00Multiple Myeloma
00:01:53Introduction: ESMO 2026; Recent FDA Approvals
00:02:46Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial
00:19:16Bispecific Antibodies — Dr Lonial
00:37:08Antibody-Drug Conjugates — Dr Richardson
00:50:10Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson

TRANSKRIPTIO 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

HAE EDELLISIÄ EPISODEJA

Hae kanavan Hematologic Oncology Update vanhoja jaksoja.
Upota tämä hakupalkki verkkosivustollesi

MUITA jaksoja TÄSSÄ PODCASTISSA

Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Ann LaCasce and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) First-Line Treatment (1:33) Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy (20:36) CME information and select publications
00:50:22
JAA
TALLENNA
Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Featuring perspectives from Dr Catherine C Coombs and Dr Matthew S Davids, including the following topics: Introduction (0:00) Minimal Residual Disease Assays in Community-Based Practice (1:24) New Developments in Previously Untreated Chronic Lymphocytic Leukemia (CLL) — Dr Davids (8:12) Richter T…
00:58:15
JAA
TALLENNA
Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Featuring an interview with Dr L Elizabeth Budde, including the following topics: Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00) Management of BsAb-induced cytokine release syndrome and other toxicities (7:35) Use of BsAbs in the f…
00:47:06
JAA
TALLENNA
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting

Featuring perspectives from Dr Meletios-Athanasios (Thanos) C Dimopoulos, Dr Robert Z Orlowski and Dr Noopur Raje, moderated by Dr Orlowski, including the following topics: Introduction (0:00) New and Emerging Strategies with Bispecific Antibodies in Multiple Myeloma (MM) — Dr Raje (2:20) Utility …
00:59:31
JAA
TALLENNA
Chronic Lymphocytic Leukemia — Microlearning Activity 1

Chronic Lymphocytic Leukemia — Microlearning Activity 1

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00) Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor the…
00:24:32
JAA
TALLENNA
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin Dr. Neil Love:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.
PROMOTED
The best Podcast API & MCP to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API & MCP to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

SUOSITUKSET
Käytä API:a tämän episodin hakemiseen